Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa.
about
Reaction Products and the X-ray Structure of AmpDh2, a Virulence Determinant of Pseudomonas aeruginosaCell-Wall Remodeling by the Zinc-Protease AmpDh3 from Pseudomonas aeruginosaActivation by Allostery in Cell-Wall Remodeling by a Modular Membrane-Bound Lytic Transglycosylase from Pseudomonas aeruginosaReactions of the three AmpD enzymes of Pseudomonas aeruginosaBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsIn vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa.Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.Beta-lactam antibiotics: from antibiosis to resistance and bacteriologyThe sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa.Beyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesAmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Three Yersinia enterocolitica AmpD Homologs Participate in the Multi-Step Regulation of Chromosomal Cephalosporinase, AmpC.AmpC beta-lactamases.Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.Bacterial cell-wall recycling.Gene and Protein Network Analysis of AmpC β Lactamase.OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?Orthologous and Paralogous AmpD Peptidoglycan Amidases from Gram-Negative Bacteria.Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing.Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpCGenetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosaThe genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach.Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa.AmpG is required for BlaXc beta-lactamase expression in Xanthomonas campestris pv. campestris str. 17.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.Antibiotic resistance: a rundown of a global crisis
P2860
Q27678883-8343CF92-3EA0-44BD-8CCD-B6F589B04E44Q27679476-46306B27-3E62-4086-AB1E-CEA09AE02BEFQ27728048-9E605C28-C648-4CDC-B607-0646D80638F4Q28493213-C539FC94-FCFA-4C8B-B10C-80E9E4E0B1FCQ30235064-843E13E9-E524-4DE6-AC94-07CB50F2990EQ30819461-35151713-6E17-40DB-A774-AD2633E880FDQ33422951-521BFE5A-273A-4E55-9909-0415D700B7F0Q33564290-C82A6069-C16A-41FB-B68A-362CBBBA24D5Q33951933-F6736140-A560-45E9-A5B4-4AF4F6611020Q34167642-E5375033-12DC-4421-9EA6-3F346FB30D26Q34266074-54C67724-DF2B-4469-9946-8306BBDB1B97Q34933120-4A645B1A-8446-4F88-AAFB-3ECAD05EFA93Q35007624-1C22E9FA-F1FD-45A1-B042-8760486B58DAQ35867391-15DE8150-CE14-4971-87B1-4E6B6A3764C5Q36757725-1D2F7480-10AC-4CA2-8E8D-785D80176DB2Q37184346-27B57E79-3E17-46DD-B9A0-123D410BEAD6Q37366249-49A0477F-5C62-4932-A4B1-DC9F95B14CF1Q37961906-3DABABD3-8154-4978-B9CC-61C38DF6E9ABQ38060821-C53702CA-045D-4884-BB57-A7855D0FCB6BQ38470588-B02B72C8-0FBB-460A-A22C-246D1683274BQ38626877-0DEA791D-D205-4823-A2A7-52DB4750E287Q38626934-DFE852EE-0E40-4FDA-B68E-72DD40531768Q38741337-F6AC46CC-77DC-47D1-A2B9-BC4194A4FDE7Q38802410-64746C21-3638-42CA-9166-C6F12F643710Q38871841-5193FDE5-85BE-44FB-9BF7-F323623210E3Q39218893-A59DAFDD-EA76-4572-AA20-3CA50BE16BCFQ39683346-2FC4E0BC-DB35-4966-9563-18E3228B9893Q40559371-221B4236-C087-46E9-A7F4-F5D839DF1E84Q41036103-A9AAD6EA-5C8B-47A7-ADD9-A4AB3DE1852CQ41075944-BC4714B2-6F60-4375-8EA5-55CCB798C586Q41183478-8B574407-022E-4021-8CDD-8F64505065B2Q41834172-562418EB-47A2-432B-AFB7-EC76F43ECDB5Q42249771-D26FD51D-FB78-4FEB-8BFF-73EB6FAD7541Q42430253-0D288390-26CD-493C-8A46-E0893C970D17Q42659717-E50FC2A0-D33D-4411-B96C-0476F09EF5ACQ43121813-90EA783C-483B-494C-8ABD-BEEED42E3C70Q44318915-4B2FC626-5C7E-454B-95B0-42CE16F15EE3Q46286684-37AA0B6B-156E-45F9-9795-33CC7F4DCDB3Q57816209-01E02A36-CE56-457C-B871-87C6F1E59244
P2860
Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@en
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@nl
type
label
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@en
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@nl
prefLabel
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@en
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Benefit of having multiple amp ...... nce in Pseudomonas aeruginosa.
@en
P2093
Antonio Oliver
Bartolomé Moya
José L Pérez
Sebastián Albertí
P2860
P304
P356
10.1128/AAC.00172-08
P407
P50
P577
2008-07-21T00:00:00Z